ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 12455 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 12455; 2) Community: the network communities that were significantly associated with the response to NSC 12455; 3) Molecule: the relationships between components within communities and NSC 12455; 4) MDR: the compounds that were significantly associated with the NSC 12455.

NSC Compound Enrichment Correlation
NSC 749117 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline 0.0181211508101519 0.25377396
NSC 750441 Null 0.0181211508101519 0.12444524
NSC 750743 (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0181211508101519 0.19603237
NSC 764037 BP-1-102 0.0181211508101519 0.26975743
NSC 83492 Null 0.0181211508101519 0.34126974
NSC 736829 6-(5-Aminopentyl)-5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]i soquinoline Hydrochloride 0.0187206825450445 0.51534396
NSC 105132 Deoxycamptothecin 0.0208632511155816 0.18511691
NSC 114340 Ophiobolin A 0.0208632511155816 0.49533133
NSC 13275 Null 0.0208632511155817 0.33332829
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0208632511155817 0.29063283
Total:134  Current:69    [First] [Prev] [Next] [Last]